Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cefazolin
Drug ID BADD_D00382
Description A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.
Indications and Usage Mainly used to treat bacterial infections of the skin. It can also be used to treat moderately severe bacterial infections involving the lung, bone, joint, stomach, blood, heart valve, and urinary tract. It is clinically effective against infections caused by staphylococci and streptococci species of Gram positive bacteria. May be used for surgical prophylaxis; if required metronidazole may be added to cover B. fragilis.
Marketing Status Prescription; Discontinued
ATC Code J01DB04
DrugBank ID DB01327
KEGG ID D02299
MeSH ID D002437
PubChem ID 33255
TTD Drug ID D09KDN
NDC Product Code 71872-7141; 0781-3450; 50090-4256; 44567-706; 72572-055; 71872-7027; 0143-9665; 0404-9833; 67184-1001; 0143-9924; 0143-9983; 60505-6142; 52584-923; 0143-9261; 44567-707; 0781-3452; 0781-3451; 70518-3047; 67184-0560; 17337-0300; 0143-9262; 0404-9834; 52584-087; 0143-9923; 60505-6231; 52584-924; 44567-120; 0404-9835; 72572-056; 0409-2585; 60505-6143; 44567-708
Synonyms Cefazolin | Cephazolin | Cefamedin | Cefamezine | Cephamezine | Gramaxin | Kefzol | Totacef | Ancef | Cefazolin Sodium | Sodium, Cefazolin | Sodium Cephazolin | Cephazolin, Sodium | Cephazolin Sodium | Sodium, Cephazolin
Chemical Information
Molecular Formula C14H14N8O4S3
CAS Registry Number 25953-19-9
SMILES CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Cardio-respiratory arrest22.02.06.007; 02.03.04.0020.000111%Not Available
Cardiogenic shock24.06.02.006; 02.05.01.0030.000056%Not Available
Cellulitis23.09.01.001; 11.02.01.0010.000319%Not Available
Cerebrovascular accident24.03.05.001; 17.08.01.007--
Cheilitis23.03.03.025; 07.05.01.001--
Chest discomfort22.02.08.001; 08.01.08.019; 02.02.02.0090.000319%Not Available
Cholangitis sclerosing09.02.01.003; 10.04.09.0020.000532%Not Available
Cholestasis09.01.01.0010.000213%Not Available
Circulatory collapse24.06.02.0010.000213%Not Available
Coagulopathy01.01.02.0010.000532%Not Available
Colitis07.08.01.001--
Confusional state19.13.01.001; 17.02.03.0050.000639%
Cough22.02.03.001--
Death08.04.01.001--
Depressed level of consciousness17.02.04.0020.000213%
Dermatitis23.03.04.002--Not Available
Diarrhoea07.02.01.001--
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Drug eruption08.01.06.015; 23.03.05.001; 10.01.01.0050.000319%Not Available
Drug hypersensitivity10.01.01.0010.004577%Not Available
Dry eye06.08.02.0010.000213%
Dry mouth07.06.01.0020.000213%
Dyspepsia07.01.02.001--
Dysphagia07.01.06.003--
Dyspnoea22.02.01.004; 02.01.03.0020.001490%
Electrocardiogram ST segment abnormal13.14.05.0170.000532%Not Available
Eosinophilia01.02.04.0010.000532%
Epistaxis24.07.01.005; 22.04.03.0010.000213%
Erythema23.03.06.0010.001703%Not Available
Erythema multiforme23.03.01.003; 10.01.03.015--
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 7 Pages